Related Experiment Video
Updated: Aug 23, 2025

06:31
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
8.7K
Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech).
Sonali Batta1, Austinn C Miller2, Susuana Adjei2
1Texas A&M College of Medicine, Temple, Texas.
Summary
Erythema multiforme (EM) can occur after COVID-19 booster shots, even if previous doses caused no skin reactions. This case highlights the importance of monitoring for EM post-vaccination.
Area of Science:
- Dermatology
- Vaccinology
- Immunology
Background:
- COVID-19 vaccination programs aim for widespread immunity.
- Cutaneous adverse reactions to vaccines are monitored for safety.
- Erythema multiforme is an immune-mediated skin condition.
Observation:
- A patient developed erythema multiforme (EM) after receiving a third, or booster, dose of a COVID-19 vaccine.
- This individual had no prior skin reactions following the initial two vaccine doses.
Findings:
- This is the first reported instance of vaccine-associated erythema multiforme following a COVID-19 booster vaccination.
- The case demonstrates that EM can manifest after subsequent vaccine doses despite prior tolerance.
Implications:
- Healthcare providers should maintain vigilance for erythema multiforme in patients presenting after COVID-19 vaccination.
- The potential for delayed or booster-specific cutaneous reactions necessitates ongoing surveillance of vaccine safety.
- This finding underscores the importance of considering vaccination history in the differential diagnosis of erythema multiforme.
Related Concept Videos
Myocarditis III: Medical Management
13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Cross-reactivity
31.4K
Overview
31.4K
Vaccinations
45.2K
Overview
45.2K
Myocarditis II: Clinical Features and Diagnostic Tests
19
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
Allergic Reactions
28.1K
Overview
28.1K
Allergic Drug Reactions
931
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
931

